Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2014

Open Access 01-12-2014 | Research

Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma

Authors: Zhe-yuan Hu, Sheng-xian Yuan, Yuan Yang, Wei-ping Zhou, Hua Jiang

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2014

Login to get access

Abstract

Background

Karyopherin alpha 2 (KPNA2) promotes tumor growth in hepatocellular carcinoma (HCC). We aimed to determine the content and clinical significance of mechanism underlying.

Methods

The association of transcriptional factor pleomorphic adenoma gene 1 (PLAG1) with KPNA2 was explored by co-immunoprecipitation. In vitro gain- and loss-of-function models were established to explore the functional interaction. Clinical samples from 314 HCC patients were applied to explore the clinical significance.

Results

We found that PLAG1 could associate with KPNA2 and be promoted into nucleus by KPNA2. The increment of proliferative and metastatic abilities by KPNA2 over-expression can be significantly retarded by PLAG1 inhibition. The co-enrichment of KPNA2 and PLAG1 in nucleus is observed in clinical samples and can distinguish patients with the worst prognosis. The positive PLAG1 expression is an independent risk factor of recurrence free survival (HR: 1.766, 1.315-2.371; P = 0.000) and overall survival (HR: 1.589, 1.138-2.220; P = 0.007). Especially for patients with positive KPNA2 staining (N = 152), the positive PLAG1 expression is the sole risk factor for both recurrence free survival (HR: 1.749, 1.146-2.670; P = 0.010) and overall survival (HR: 1.662, 1.007-2.744; P = 0.047).

Conclusions

The nuclear import of PLAG1 by KPNA2 is essential for the role of KPNA2 in HCC cells and is significant to predict poor survival of HCC patients after hepatectomy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322/caac.20138.CrossRefPubMed Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322/caac.20138.CrossRefPubMed
2.
go back to reference Forner A, Llovet JM, Bruix J: Hepatocellular carcinoma. Lancet. 2012, 379 (9822): 1245-1255. 10.1016/S0140-6736(11)61347-0.CrossRefPubMed Forner A, Llovet JM, Bruix J: Hepatocellular carcinoma. Lancet. 2012, 379 (9822): 1245-1255. 10.1016/S0140-6736(11)61347-0.CrossRefPubMed
3.
go back to reference Fan MQ, Huang CB, Gu Y, Xiao Y, Sheng JX, Zhong L: Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. J Exp Clin Cancer Res. 2013, 32 (1): 21-10.1186/1756-9966-32-21.PubMedCentralCrossRefPubMed Fan MQ, Huang CB, Gu Y, Xiao Y, Sheng JX, Zhong L: Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. J Exp Clin Cancer Res. 2013, 32 (1): 21-10.1186/1756-9966-32-21.PubMedCentralCrossRefPubMed
4.
go back to reference Wang YH, Dong YY, Wang WM, Xie XY, Wang ZM, Chen RX, Chen J, Gao DM, Cui JF, Ren ZG: Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-kappaB pathways induced by paracrine cytokines. J Exp Clin Cancer Res. 2013, 32 (1): 51-10.1186/1756-9966-32-51.PubMedCentralCrossRefPubMed Wang YH, Dong YY, Wang WM, Xie XY, Wang ZM, Chen RX, Chen J, Gao DM, Cui JF, Ren ZG: Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-kappaB pathways induced by paracrine cytokines. J Exp Clin Cancer Res. 2013, 32 (1): 51-10.1186/1756-9966-32-51.PubMedCentralCrossRefPubMed
5.
go back to reference Kau TR, Way JC, Silver PA: Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer. 2004, 4 (2): 106-117. 10.1038/nrc1274.CrossRefPubMed Kau TR, Way JC, Silver PA: Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer. 2004, 4 (2): 106-117. 10.1038/nrc1274.CrossRefPubMed
6.
go back to reference Conti E, Muller CW, Stewart M: Karyopherin flexibility in nucleocytoplasmic transport. Curr Opin Struct Biol. 2006, 16 (2): 237-244. 10.1016/j.sbi.2006.03.010.CrossRefPubMed Conti E, Muller CW, Stewart M: Karyopherin flexibility in nucleocytoplasmic transport. Curr Opin Struct Biol. 2006, 16 (2): 237-244. 10.1016/j.sbi.2006.03.010.CrossRefPubMed
7.
go back to reference Christiansen A, Dyrskjot L: The functional role of the novel biomarker karyopherin alpha 2 (KPNA2) in cancer. Cancer Lett. 2013, 331 (1): 18-23. 10.1016/j.canlet.2012.12.013.CrossRefPubMed Christiansen A, Dyrskjot L: The functional role of the novel biomarker karyopherin alpha 2 (KPNA2) in cancer. Cancer Lett. 2013, 331 (1): 18-23. 10.1016/j.canlet.2012.12.013.CrossRefPubMed
8.
go back to reference Altan B, Yokobori T, Mochiki E, Ohno T, Ogata K, Ogawa A, Yanai M, Kobayashi T, Luvsandagva B, Asao T, Kuwano H: Nuclear karyopherin-alpha2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis. 2013, 34 (10): 2314-21. 10.1093/carcin/bgt214.CrossRefPubMed Altan B, Yokobori T, Mochiki E, Ohno T, Ogata K, Ogawa A, Yanai M, Kobayashi T, Luvsandagva B, Asao T, Kuwano H: Nuclear karyopherin-alpha2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis. 2013, 34 (10): 2314-21. 10.1093/carcin/bgt214.CrossRefPubMed
9.
go back to reference Mortezavi A, Hermanns T, Seifert HH, Baumgartner MK, Provenzano M, Sulser T, Burger M, Montani M, Ikenberg K, Hofstadter F, Hartmann A, Jaggi R, Moch H, Kristiansen G, Wild PJ: KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res. 2011, 17 (5): 1111-1121. 10.1158/1078-0432.CCR-10-0081.CrossRefPubMed Mortezavi A, Hermanns T, Seifert HH, Baumgartner MK, Provenzano M, Sulser T, Burger M, Montani M, Ikenberg K, Hofstadter F, Hartmann A, Jaggi R, Moch H, Kristiansen G, Wild PJ: KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res. 2011, 17 (5): 1111-1121. 10.1158/1078-0432.CCR-10-0081.CrossRefPubMed
10.
go back to reference Jiang J, Sliva D: Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. Int J Oncol. 2010, 37 (6): 1529-1536.PubMed Jiang J, Sliva D: Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. Int J Oncol. 2010, 37 (6): 1529-1536.PubMed
11.
go back to reference Li C, Ji L, Ding ZY, Zhang QD, Huang GR: Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma. Tumour Biol. 2013, 34 (2): 1021-1026. 10.1007/s13277-012-0641-7.CrossRefPubMed Li C, Ji L, Ding ZY, Zhang QD, Huang GR: Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma. Tumour Biol. 2013, 34 (2): 1021-1026. 10.1007/s13277-012-0641-7.CrossRefPubMed
12.
go back to reference Yoshitake K, Tanaka S, Mogushi K, Aihara A, Murakata A, Matsumura S, Mitsunori Y, Yasen M, Ban D, Noguchi N, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S: Importin-alpha1 as a novel prognostic target for hepatocellular carcinoma. Ann Surg Oncol. 2011, 18 (7): 2093-2103. 10.1245/s10434-011-1569-7.CrossRefPubMed Yoshitake K, Tanaka S, Mogushi K, Aihara A, Murakata A, Matsumura S, Mitsunori Y, Yasen M, Ban D, Noguchi N, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S: Importin-alpha1 as a novel prognostic target for hepatocellular carcinoma. Ann Surg Oncol. 2011, 18 (7): 2093-2103. 10.1245/s10434-011-1569-7.CrossRefPubMed
13.
go back to reference Braem CV, Kas K, Meyen E, Debiec-Rychter M, Van De Ven WJ, Voz ML: Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal. J Biol Chem. 2002, 277 (22): 19673-19678. 10.1074/jbc.M112112200.CrossRefPubMed Braem CV, Kas K, Meyen E, Debiec-Rychter M, Van De Ven WJ, Voz ML: Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal. J Biol Chem. 2002, 277 (22): 19673-19678. 10.1074/jbc.M112112200.CrossRefPubMed
14.
go back to reference Zatkova A, Rouillard JM, Hartmann W, Lamb BJ, Kuick R, Eckart M, von Schweinitz D, Koch A, Fonatsch C, Pietsch T, Hanash SM, Wimmer K: Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer. 2004, 39 (2): 126-137. 10.1002/gcc.10307.CrossRefPubMed Zatkova A, Rouillard JM, Hartmann W, Lamb BJ, Kuick R, Eckart M, von Schweinitz D, Koch A, Fonatsch C, Pietsch T, Hanash SM, Wimmer K: Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer. 2004, 39 (2): 126-137. 10.1002/gcc.10307.CrossRefPubMed
15.
go back to reference Matsuyama A, Hisaoka M, Hashimoto H: PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study. Virchows Arch. 2011, 459 (5): 539-545. 10.1007/s00428-011-1149-z.CrossRefPubMed Matsuyama A, Hisaoka M, Hashimoto H: PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study. Virchows Arch. 2011, 459 (5): 539-545. 10.1007/s00428-011-1149-z.CrossRefPubMed
16.
go back to reference Van Dyck F, Declercq J, Braem CV, Van de Ven WJ: PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review). Int J Oncol. 2007, 30 (4): 765-774.PubMed Van Dyck F, Declercq J, Braem CV, Van de Ven WJ: PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review). Int J Oncol. 2007, 30 (4): 765-774.PubMed
17.
go back to reference Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF, Zeng WF, Sham JS, Yang M, Guan XY: Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene. 2004, 23 (1): 298-302.PubMed Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF, Zeng WF, Sham JS, Yang M, Guan XY: Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene. 2004, 23 (1): 298-302.PubMed
18.
go back to reference Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, Wu MC: Posthepatectomy HBV Reactivation in Hepatitis B-Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels. Ann Surg. 2013, 257 (3): 490-505. 10.1097/SLA.0b013e318262b218.CrossRefPubMed Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, Wu MC: Posthepatectomy HBV Reactivation in Hepatitis B-Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels. Ann Surg. 2013, 257 (3): 490-505. 10.1097/SLA.0b013e318262b218.CrossRefPubMed
19.
go back to reference Hoshida Y: Molecular signatures and prognosis of hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2011, 57 (3): 311-322.PubMed Hoshida Y: Molecular signatures and prognosis of hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2011, 57 (3): 311-322.PubMed
20.
go back to reference Chen YW, Boyartchuk V, Lewis BC: Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells. Neoplasia. 2009, 11 (9): 835-845.PubMedCentralCrossRefPubMed Chen YW, Boyartchuk V, Lewis BC: Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells. Neoplasia. 2009, 11 (9): 835-845.PubMedCentralCrossRefPubMed
21.
go back to reference van der Watt PJ, Ngarande E, Leaner VD: Overexpression of Kpnbeta1 and Kpnalpha2 importin proteins in cancer derives from deregulated E2F activity. PLoS One. 2011, 6 (11): e27723-10.1371/journal.pone.0027723.PubMedCentralCrossRefPubMed van der Watt PJ, Ngarande E, Leaner VD: Overexpression of Kpnbeta1 and Kpnalpha2 importin proteins in cancer derives from deregulated E2F activity. PLoS One. 2011, 6 (11): e27723-10.1371/journal.pone.0027723.PubMedCentralCrossRefPubMed
22.
go back to reference Huang L, Wang HY, Li JD, Wang JH, Zhou Y, Luo RZ, Yun JP, Zhang Y, Jia WH, Zheng M: KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Cell Death Dis. 2013, 4: e745-10.1038/cddis.2013.256.PubMedCentralCrossRefPubMed Huang L, Wang HY, Li JD, Wang JH, Zhou Y, Luo RZ, Yun JP, Zhang Y, Jia WH, Zheng M: KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Cell Death Dis. 2013, 4: e745-10.1038/cddis.2013.256.PubMedCentralCrossRefPubMed
23.
go back to reference Krawczyk E, Hanover JA, Schlegel R, Suprynowicz FA: Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. Biochem Biophys Res Commun. 2008, 371 (4): 684-688. 10.1016/j.bbrc.2008.04.122.PubMedCentralCrossRefPubMed Krawczyk E, Hanover JA, Schlegel R, Suprynowicz FA: Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. Biochem Biophys Res Commun. 2008, 371 (4): 684-688. 10.1016/j.bbrc.2008.04.122.PubMedCentralCrossRefPubMed
24.
go back to reference Matsuyama A, Hisaoka M, Hashimoto H: PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland. Pathol Int. 2012, 62 (1): 1-7. 10.1111/j.1440-1827.2011.02740.x.CrossRefPubMed Matsuyama A, Hisaoka M, Hashimoto H: PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland. Pathol Int. 2012, 62 (1): 1-7. 10.1111/j.1440-1827.2011.02740.x.CrossRefPubMed
25.
go back to reference Patz M, Pallasch CP, Wendtner CM: Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs. Leuk Lymphoma. 2010, 51 (8): 1379-1381. 10.3109/10428194.2010.496016.CrossRefPubMed Patz M, Pallasch CP, Wendtner CM: Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs. Leuk Lymphoma. 2010, 51 (8): 1379-1381. 10.3109/10428194.2010.496016.CrossRefPubMed
26.
go back to reference von Frowein J, Pagel P, Kappler R, von Schweinitz D, Roscher A, Schmid I: MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology. 2011, 53 (3): 833-842. 10.1002/hep.24125.CrossRefPubMed von Frowein J, Pagel P, Kappler R, von Schweinitz D, Roscher A, Schmid I: MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology. 2011, 53 (3): 833-842. 10.1002/hep.24125.CrossRefPubMed
27.
go back to reference Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang DY, Sole M, Thung S, Moyano S, Toffanin S, Minguez B, Cabellos L, Peix J, Schwartz M, Mazzaferro V, Bruix J, Llovet JM: IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol. 2010, 52 (4): 550-559. 10.1016/j.jhep.2010.01.015.PubMedCentralCrossRefPubMed Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang DY, Sole M, Thung S, Moyano S, Toffanin S, Minguez B, Cabellos L, Peix J, Schwartz M, Mazzaferro V, Bruix J, Llovet JM: IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol. 2010, 52 (4): 550-559. 10.1016/j.jhep.2010.01.015.PubMedCentralCrossRefPubMed
Metadata
Title
Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma
Authors
Zhe-yuan Hu
Sheng-xian Yuan
Yuan Yang
Wei-ping Zhou
Hua Jiang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2014
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/s13046-014-0061-1

Other articles of this Issue 1/2014

Journal of Experimental & Clinical Cancer Research 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine